Cargando…
Clinical characteristics and prenatal diagnosis for 22 families in Henan Province of China with X-linked agammaglobulinemia (XLA) related to Bruton’s tyrosine kinase (BTK) gene mutations
BACKGROUND: X-linked agammaglobulinaemia (XLA) is a rare immunodeficiency disease for which recurrent severe infection is the major clinical symptom. BTK is the main causative gene, with X chromosome recessive inheritance. However, the mutations reported to date do not fully explain the disorder. ME...
Autores principales: | Gao, Shanshan, Hu, Shuang, Duan, Huikun, Wang, Li, Kong, Xiangdong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7302398/ https://www.ncbi.nlm.nih.gov/pubmed/32552675 http://dx.doi.org/10.1186/s12881-020-01063-5 |
Ejemplares similares
-
Deletion within the Src homology domain 3 of Bruton's tyrosine kinase resulting in X-linked agammaglobulinemia (XLA)
Publicado: (1994) -
A novel Bruton’s tyrosine kinase gene (BTK) missense mutation in a Chinese family with X-linked agammaglobulinemia
por: Zheng, Bixia, et al.
Publicado: (2014) -
Bruton's Agammaglobulinemia and COVID-19
por: Hovey, Justin G, et al.
Publicado: (2020) -
A mutation in the promoter region of BTK causes atypical XLA
por: Bravo García-Morato, María, et al.
Publicado: (2020) -
X-linked agammaglobulinemia (XLA): Phenotype, diagnosis, and therapeutic challenges around the world
por: El-Sayed, Zeinab A., et al.
Publicado: (2019)